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Summary  
Unlimitedly proliferating cells need to acquire the telomere DNA maintenance 
mechanism, to counteract possible shortening through multiple rounds of replication 
and segregation of linear chromosomes. Most human cancer cells express telomerase 
whereas the other cells utilize the alternative lengthening of telomeres (ALT) pathway 
to elongate telomere DNA. It is suggested that ALT depends on the recombination 
between telomere repetitive DNAs. However, the molecular details remain unknown. 
Recent studies have provided evidence of special structures of telomere DNA and genes 
essential for the phenotypes of ALT cells. The molecular models of the ALT pathway 
should be validated to elucidate recombination-mediated telomere maintenance and 
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Introduction 
Telomeres are specific chromatin structures at the linear chromosome ends of 
eukaryotic cells. Each telomere contains an end of a double-stranded (ds) DNA, which 
is protected from degradation and repair processes that can cause chromosome 
instability. This end protection requires functional telomere chromatin that includes 
specialized DNA (telomere DNA) and its binding proteins (telomere binding proteins) 
(Fig. 1A, B). The telomere DNA of most eukaryotes is repetitive DNA containing a 
guanine-rich (in human, 5’-TTAGGG-3’) strand and its complementary strand called G- 
and C-strands, respectively. The 3’-end of G-strand extends to form a single-stranded 
(ss) structure called the G-tail (1). The G-tail is thought to invade and hybridize with the 
proximal C-strand to form a special structure called the t-loop (2). Shelterin is a 
conserved protein complex on telomeres, and shelterin in mammalian cells is composed 
of one ss (POT1) and two ds (TRF1 and TRF2) telomere DNA binding proteins as well 
as specific proteins to connect those DNA binding proteins (3, 4). This complex serves 
as the functional framework of telomere chromatin. 
Telomere DNA in dividing cells is subject to possible shortening or the 
so-called end-replication problem (Fig. 1C) (5, 6). Semi-conservative replication cannot 
complete the syntheses of the very ends of linear DNA. Thus after multiple rounds of 
cell division, human somatic cells have shortened telomere DNA, which results in 
irreversible cell growth arrest, namely, replicative senescence (7, 8). On the other hand, 
cancer cells express certain mechanisms to counteract the shortening of telomere DNA 
and acquire immortality. Telomerase is a specific reverse transcriptase that elongates 
the G-strand telomere DNA (9). Approximately 90 % of cancer cells maintain telomeres 
in a telomerase-dependent manner; however, some telomerase-negative human cell 
lines have been established from cancer cells and in vitro immortalized cells (10). Thus, 
it is imperative to understand both telomerase-dependent and telomerase-independent 
pathways to inhibit the immortality of cancer cells. 
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In yeast and mouse, telomerase-negative cells have been directly isolated 
from “survivors” after artificial disruption of the gene encoding the telomerase RNA 
component (telomere RNA: TR) or the catalytic subunit (telomere reverse transcriptase: 
TERT). Survivors in fission yeast Schizosaccharomyces pombe occasionally develop 
self-circularized chromosomes to circumvent the end-replication problem (11, 12), 
whereas survivors in other species generally acquire the lengthening mechanism of 
telomere DNA at linear chromosome ends (Fig. 1D) (13-15). Phenotypic variations 
among telomerase-negative cells gave birth to the idea that there may be more than one 
telomerase-independent pathway. One of the most significant examples is the 
alternative lengthening of telomeres (ALT) pathway of human cells. Confusingly, 
“ALT” is sometimes used for various telomerase-independent pathways in human and 
other species. The ALT we describe here is confined to the pathway found in a group of 
human telomerase-negative cells (hereafter, ALT cells) showing two distinctive 
telomere phenotypes; heterogeneous and long telomere DNA and the formation of 
ALT-associated promyelocytic leukemia (PML) body (APB). These phenotypes are 
widely used as convenient markers for ALT cell lines. In this review, we will 
summarize the characteristics and the most recent findings of the human ALT pathway. 
We will also discuss the molecular mechanism of ALT and its relevance to diverse 
telomerase-independent pathways. 
 
Telomere DNA length and recombination in ALT cells 
Telomere DNA length is generally analyzed by the Southern hybridization of genomic 
DNA treated with appropriate restriction enzymes. The mean length of telomere in 
human telomerase-positive cancer cell lines is usually < 10 kb. In contrast, ALT cells 
have longer and more heterogeneous telomeres; the mean length is ~ 20 kb (16). This 
suggests that ALT is a distinct lengthening mechanism from the telomerase pathway 
and telomere length analysis is regarded as one of the vital tests for ALT. A fluorescent 
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in situ hybridization (FISH) experiment of metaphase chromosomes also demonstrated 
the remarkable heterogeneity of telomere lengths in ALT cells. The signal strengths of 
the telomere foci in ALT cells varied markedly, whereas those in telomerase-positive 
cells were comparable between chromosome ends (17). It is unknown how the 
heterogeneity of telomere lengths developed; however, it may be related to telomere 
metabolism specific to ALT cells. 
 The dynamic behaviour of telomere length in ALT cells was described in a 
study that used cells with artificially tagged telomeres (18). A tag sequence inserted 
near the telomere repeats of a defined chromosome end was used as a probe to measure 
the length of this telomere DNA specifically. The telomere in an ALT cell line was 
drastically elongated during cell division, which differed from that in 
telomerase-positive cells. The telomeres also showed gradual shortening similar to 
normal somatic cells and sometimes exhibited rapid deletion. The rapid changes in the 
telomere DNA length of this ALT cell line suggest homologous recombination (HR) 
between telomeres. Another study demonstrated that a tag sequence within the telomere 
repeats of one chromosome was duplicated to other chromosome ends through cell 
division in ALT cells but not in telomerase-positive cells (19). This recombination 
event may reflect the ALT pathway in which telomeres are elongated by making a copy 
of the telomere DNAs of different chromosomes. 
 It is possible that ALT cells represent elevated levels of HR at other loci as 
well as telomere repeats. The instability of the repetitive sequences of minisatellites was 
more frequently noted in ALT cell lines than in telomerase-positive cell lines (20, 21). 
However, ALT-specific hyper-recombination was not observed when the frequencies of 
intrachromosomal recombination were analyzed by using a reporter construct integrated 
into a certain chromosome locus (22). Therefore, ALT cells may have the feature of 
elevated recombination only in the loci with repetitive sequences, such as telomeres and 
minisatellites. 
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 To visualize de novo synthesized telomeric G- or C-strand specifically, 
chromosome orientation (CO)-FISH analysis was applied to telomeres (Fig. 2). In 
metaphase chromosomes, the CO-FISH signal was typically observed at the telomere of 
either one of the sister chromatids. The frequencies of telomere-sister-chromatid 
exchange (T-SCE) were calculated as the percentage of chromosome ends positive for 
CO-FISH signals on both sister telomeres. The high level of T-SCE was generally 
found in ALT but not in telomerase-positive cells (23-25) and therefore, 
hyper-recombination between sister telomeres was recognized as one of the features of 
ALT cells. However, T-SCE or the reciprocal exchange of sister telomeres by itself 
does not accompany massive DNA synthesis and could not account for the net 
elongation of telomeres or the ALT pathway. 
 
Particular structures of telomere DNA in ALT cells 
The first evidence of unusual telomere DNA in ALT cells is the extrachromosomal 
telomere repeat (ECTR). FISH analyses of metaphase chromosomes of ALT cells 
suggested the presence of significant telomere DNA repeats other than the chromosome 
ends (26). ALT cells harbor small ds linear telomere DNA in the soluble fractions of the 
cell extract, which can be separated from bulk chromatin (27). Circular DNA molecules 
were occasionally found in ALT cells by electron microscopy and these are thought to 
correspond to the circular form of telomere DNA (t-circle) determined by 
two-dimensional (2D) gel electrophoresis (28, 29). T-circles are now regarded as a 
marker for ALT cells, although they can be observed in telomerase-positive cells that 
have a defect in TRF2 or that contain extensively elongated telomere DNA (29, 30). 
T-circles can be produced by the intrachromosomal recombination of telomere repeats 
(Fig. 3A). ALT cells may acquire a feature that induces such recombination events. 
 ALT cells harbour in particular ss structures of telomere DNA (31). The 
average lengths of ss telomere DNA are shorter than those of ds telomere DNA, 
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suggesting that telomere in ALT cells contains nicked and/or gapped structures. 
Different forms of ss telomere DNA were resolved by 2D gel electrophoresis. The small 
sized ones of G- and C-strands were separated in the electrophoresis and showed the 
different sensitivities to structure-specific nucleases: The single G-strand structure 
(ss-G) was concluded to be linear DNA whereas the single C-strand structure (ss-C) was 
circular DNA. A sensitive method to detect circular C-strands was developed and 
applied to examine various cell lines (32). Interestingly, ALT cell lines were positive for 
the circular C-strands whereas telomerase-positive cells were negative. This suggests 
that this “C-circle (CC) assay” is useful to determine whether the tested cancer cells are 
ALT or not. In addition, branched molecules of telomere DNA were found in the ss 
telomere structures of ALT cells. These remarkable structures of telomere DNA, 
t-circles and various ss structures, must be specific intermediates or crucial substrates 
for telomere metabolism in the ALT pathway. 
 The ALT pathway must be mediated by some HR-based mechanism where 
the nascent telomere DNA is synthesized efficiently. That is, the ALT pathway could 
induce pairing of the G- and C-strands in trans by HR to form the primer and the 
template. DNA synthesis should follow to elongate telomere DNA from the primer. One 
possible mechanism is break-induced replication (BIR). In BIR, the 3’ -end of ss DNA 
invades a region with a homologous sequence at first, and then DNA synthesis is 
initiated at the 3’ -end by using the paired strand as template. It has been suggested that 
BIR must operate in the telomere lengthening in ALT cells (Fig. 3B). When the 3’-end 
of the G-tail is paired with the C-strand of other telomeres, a nascent G-strand can be 
synthesized and elongated up to the end of the template C-strand. BIR readily accounts 
for the high frequency of copy of a tag in telomere DNA (19), although the function of 
circular telomere DNA specifically found in ALT cells (t-circle and ss-C) is unclear. 
 The integration of t-circles into the telomere repeats at chromosome ends will 
result in telomere elongation (Fig. 3C). However, it does not increase the net amount of 
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telomere DNA in the cells and cannot complete telomere maintenance through multiple 
divisions of ALT cells. Furthermore, circular forms of DNA can be involved in the 
rapid elongation of DNA ends in rolling-circle replication (RCR) (Fig. 3D). When the 
3’-end of the G-tail is paired with ss-C and/or t-circles in ALT cells, the synthesis of the 
G-strand can be induced on this circular DNA as a template. RCR is fundamentally a 
continuous process and can accomplish very efficient lengthening even with small 
templates. Interestingly, the ss-G structure in ALT cells is similar to the linear ss 
intermediates of RCR in yeast mitochondria DNA (33). BIR and RCR are not exclusive 
of each other and both require invasion of the 3’-end of the G-tail with the C-strand and 
the initiation of DNA synthesis at the pairing sites. This implies that both mechanisms 
may contribute to the ALT pathway and be regulated by common molecular 
mechanisms. 
 
ALT-associated PML body 
PML body is a nuclear aggregate of PML and other proteins and is insensitive to low 
concentration of non-ionic detergent. PML bodies are present in many types of cells, 
e.g., in both telomerase-positive and ALT cell lines. It has been suggested that PML 
body functions in various cellular processes, including tumor formation, cellular 
senescence, stress response, DNA repair, etc. However, its molecular function(s) 
remains unsolved. Although PML bodies are usually unrelated to telomere, many 
telomerase-negative cell lines commonly have ALT-associated PML body (APB), a 
special form of PML body that includes telomere DNA and chromatin (34). This feature, 
namely, the colocalization of both markers for telomere and PML body, can be readily 
observed and thus, the formation of APB has been used as a marker for ALT cells. 
Although it is unknown how APBs are related to the ALT pathway, it is noteworthy that 
APBs possess a variety of proteins working in DNA metabolism and cell growth 
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regulation (Table 1). The localization of recombination proteins at APBs supports the 
idea that HR may be associated with ALT. 
 The incorporation of the thymidine analog bromodeoxyuridine (BrdU) was 
observed in a fraction of APBs (35). This nascent DNA synthesis at APBs was 
suppressed by inhibitors of ATM and ATR (36), which are members of 
phosphoinositide 3-kinase related kinase (PIKK) crucial for the activation of DNA 
damage response (DDR). This suggests that the ALT pathway may be regulated by 
damage signaling. Telomeres of ALT cells are colocalized with the markers for DDR, 
for example, !-H2AX, 53BP1, the RAD9-RAD1-HUS1 (9-1-1) complex, and its loader 
RAD17 (36, 37). However, it is unknown whether DDR of telomere in ALT cells is 
activated by particular ss structures of telomere DNA. Two reports suggested that APBs 
have a special form of telomere DNA. The major telomere DNA components in APB 
are chromosome ends; thus the chromosome ends may cluster at APBs to enhance HR 
between telomeres (38). In contrast, purification study suggests that APBs 
predominantly contain linear ECTRs (39). Therefore, the specific structures of telomere 
DNA in APBs and their relevance to the ALT pathway have still to be unraveled. 
 
Proteins required by ALT cells 
To elucidate the molecular mechanism of the ALT pathway, phenotypes of ALT cells 
were examined when the function of proteins and/or the expression of their coding 
genes were suppressed or induced (Table 1). The candidate proteins of interest were the 
components of telomere chromatin, APB, and DNA metabolisms including HR. Among 
the phenotypes, changes in telomere length were particularly notable in the analyses. 
The erosion of telomere DNA from ALT cells may be due to two reasons: One is a 
defect in the ALT pathway or the lengthening mechanism of telomere DNA. This will 
gradually reduce telomere lengths as the end-replication problem emerges. The other is 
the imperfect protection of telomere. As telomere DNA in ALT cells contains 
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remarkable ss and/or branched structures, ALT cells may be sensitive to even small 
damages in the telomere DNA caused by certain gene mutations or overexpression. The 
defect may cause the sudden loss of telomere. In both cases, a shortened telomere DNA 
is expected to induce defects in cell growth and/or cellular senescence. In addition, 
ALT-specific phenotypes, for example, the formation of APB and the frequency of 
T-SCE, were also examined. 
 
MRN complex 
The MRN complex, which includes MRE11, RAD50, and NBS1, functions in the early 
steps of HR and ds DNA break (DSB) repair (DSBR). Interestingly, this complex 
constitutes APB and the homologous complex in budding yeast plays essential roles in 
the telomerase-independent telomere lengthening mechanism (see below). 
Overexpression of Sp-100, a component of PML body that can interact with NBS1, 
inhibited the proper localization of NBS1 to APBs. This sequestration of NBS1 from 
APBs or the knockdown of each of MRN gene induced the shortening of telomere DNA 
in ALT cells (40-42). MRN was also required for APB formation (43). The knockdown 
of the gene encoding RAD50 or the overexpression of Sp-100 caused a significant 
reduction of t-circles (32, 44), suggesting the function of MRN in the maintenance of 
ALT-specific telomere DNA. 
 
TRF2 and shelterin 
TRF2 is a ds telomere DNA binding protein in the shelterin complex, which is essential 
for end protection. A defect in TRF2 stimulates chromosome fusion between telomeres 
in telomerase-positive cells (45). U2-OS is an ALT cell line established from human 
osteosarcoma, which is expressing wild type p53 and Rb, but lacking p16. The 
phenotypes of U2-OS were examined after inhibition of TRF2 by siRNA or the 
expression of the dominant-negative form of the protein (46). Telomere DNA of 
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TRF2-defecient U2-OS cells was shortened and the cells expressed "-galactosidase 
activity similar to senescent cells. The significant activation of p53 and p21 observed in 
those cells was dependent on PML protein, a major component of APB. The formation 
of APB was not affected in TRF2-deficient cells, although another report showed that 
four of six shelterin components, TRF1, TRF2, TIN2 and RAP1, were required for APB 
formation (43). 
 
RecQ-like DNA helicases 
DNA helicases of the RecQ family act on atypical DNA structures, such as 
intermediates of HR, stalled sites of replication forks and the G-quartet structure of 
telomere DNA. This function is important for genome integrity; mutations in either one 
of the three genes encoding RecQ-like DNA helicases in human, BLM (Bloom 
syndrome), WRN (Werner syndrome), or RECQL4 (RTS; Rothmund-Thomson's 
syndrome), cause chromosome abnormality and premature aging. BLM is an APB 
protein and the knockdown of the gene induces rapid shortening of telomere DNA and 
inhibition of ALT cell growth (47, 48). BLM forms a functional complex with 
topoisomerase III# (TopoIII#) to suppress HR (49). Knockdown of the TopoIII# gene in 
ALT cells also resulted in the loss of the G-tail, chromosome bridges or fusions of sister 
telomeres at anaphase, and cell growth retardation (48). The phenotypes of TopoIII# 
-knockdown cells could be due to indirect effects as the amounts of BLM and TRF2 
were concurrently decreased. 
WRN is also localized at APB, although it seems to be dispensable for ALT 
cells. When fibroblasts mutated in WRN from a Werner syndrome patient were 
immortalized with SV40, a cell line that utilizes the ALT pathway to maintain the 
telomere DNA was established (50, 51). In mouse, the survivors of Wrn (encodes WRN 
homolog) Terc (TR) double knockout were obtained and they showed elevated levels of 
T-SCE as in human ALT cells (52). These results suggest that ALT (human) and a 
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telomerase-independent lengthening mechanism (mouse) can be activated without the 
function of WRN. 
 
Resolution of Holliday junction 
A striking intermediate of HR is the Holliday junction, a cruciform structure formed by 
two ds DNAs (Fig. 4). ALT cells show elevated T-SCE and contain branched structures 
in telomere DNA, so that they may require efficient resolution of the junction. MUS81 
and its interacting protein MMS4 together constitute endonuclease specific to unpaired 
ds DNA, for example, the Holliday junction. The knockdown of MUS81 in ALT cells 
caused growth arrest, loss of telomeres on metaphase chromosomes, and reduced 
frequency of T-SCE (53). The ectopic expression of TERT complemented the 
suppression of cell growth, but not the low T-SCE frequency. Interestingly, the length 
of telomere DNA and the amount of t-circles from Southern analyses were not altered in 
MUS81 knockdown cells. It is unknown how telomere loss from chromosome ends is 
induced without a significant reduction in telomere length. 
XRCC3, a RAD51-paralog that is presumably involved in the resolution of 
the Holliday junction, is required for the maintenance of t-circles (44). RAD51D, 
another RAD51-paralog for the resolution, is an APB protein and its inhibition led to 
shortened telomere DNA and chromosome bridges (54). These RAD51-paralogs must 
be required for HR of telomere DNA in ALT cells. RAD51, which plays a central role 
in strand transfer in HR rather than the resolution of the Holliday junction, was not 
crucial for APB formation (41). It remains unknown whether RAD51 functions in the 
HR of telomere DNA and the ALT pathway. 
 
Other proteins in DNA metabolism  
FEN1 is a flap endonuclease that processes the 5’-end of Okazaki fragment to assist the 
completion of the lagging strand synthesis. The homolog of FEN1 in budding yeast 
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plays a role in the processing of the C-strand of telomere DNA. FEN1-deficient ALT 
cells showed elevated levels of DDR at telomeres (55). This response was suppressed 
by the ectopic expression of TERT. RPA is a conserved trimeric protein complex 
essential for replication and recombination. Two subunits of RPA, RPA32 and RPA70, 
are localized at APB, and the knockdown of either one of them in ALT cells resulted in 
ss G-strand accumulation and cell growth arrest (56). It needs to be clarified how crucial 
these replication proteins are for the telomere maintenance in ALT cells. 
 
Sumoylation and ubiqutination 
The PML body generally concentrates small ubiquitin-like modifier (SUMO) and 
proteins required for sumoylation. The first evidence of the function of sumoylation in 
ALT and APB was provided by a work on the SMC5/6 complex (41). SMC5/6, which 
is one of the structural maintenance of chromosomes (SMC) complexes in eukaryotes, 
plays important roles in DNA repair and DDR. The complex includes MMS21, a 
specific E3 SUMO ligase, as a non-SMC subunit. SMC5/6 and MMS21 are APB 
components and the knockdown of each of the genes caused reduced numbers of APBs 
in a cell. The knockdown of SMC5 or MMS21 in ALT cells induced telomere DNA 
shortening, telomere DNA loss at chromosome termini, cell growth suppression, and 
"-galactosidase activity expression as in senescent cells. Meanwhile, telomere DNA 
shortening and cell growth inhibition were not observed in SMC5- or MMS21-deficient 
telomerase-positive cells, suggesting their specific function in telomere maintenance 
and cell growth in ALT cells. MMS21 was able to sumoylate at least four shelterin 
proteins, TRF1, TRF2, TIN2 and RAP1. Mutated TRF1 at its sumoylated site abolished 
the localization at APB, suggesting that the sumoylation of the telomere binding 
proteins regulates APB formation. 
 FANC proteins were originally identified from mutated genes in patients with 
the genetic disease Fanconi anemia, whose cells commonly show chromosomal 
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abnormality. The localization of FANCD2 at APBs required the function of FANCA 
and FANCL, both of which are essential for the monoubiquitination of FANCD2 (57). 
The knockdown of the gene encoding FANCD2 or FANCA induced telomere loss and 
T-SCE reduction in ALT cells. In DDR, the monoubiquitination of FANCD2 and the 
formation of FANCD2 nuclear foci required ATR kinase. Interestingly, the localization 
of FANCD2 at APB was also dependent on ATR. These suggest that FANCD2 may be 
regulated by ATR-dependent monoubiquitination for its proper localization and 
function on telomere in ALT cells. 
 
Other factors related to ALT pathway 
Tumor suppressor p53 is a crucial regulator of genome stability. Human p53 is localized 
at APB in ALT cells; however, it is not necessary for APB formation (46). In an ALT 
cell line established by the transformation with the T antigen of SV40, p53 was 
activated by the knockdown of the T antigen gene. APBs of those cells were enlarged 
(58), suggesting that p53 is a positive regulator of APB formation. This effect is 
dependent on the function of p21 and heterochromatin protein HP1, both of which are 
also APB components.  
Several novel APB proteins were identified using a unique purification 
method to concentrate chromatin proteins associated with telomere DNA (59). The 
inhibition of COUP-TF2, a novel APB protein and an orphan nuclear receptor, caused a 
defect in APB formation and the shortening of telomere DNA. The molecular function 
of those novel APB proteins in the ALT pathway remains to be elucidated. 
The phenotypes of ALT cells were suppressed in hybrid cell lines of ALT and 
telomerase-positive cells (60). This suggests that ALT cells may have some recessive 
mutations in gene(s) required for the inhibition of the ALT pathway. The genes 
proposed in that study have not been identified; nevertheless, they are expected to 
provide some hints for the ALT regulation mechanism. The coexistence of ALT and the 
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lengthening by telomerase was apparently observed (17), indicating that telomerase 
activity alone is not sufficient to suppress the ALT phenotypes. This also suggests that 
some telomerase-positive cancer cells may activate the ALT pathway at the same time. 
 
Similarities in telomerase-independent lengthening mechanisms 
Cells that develop telomerase-independent lengthening mechanisms have been 
providing valuable hints for the ALT pathway. In the case of budding yeast 
Saccharomyces cerevisiae and its related species, survivors were recovered from cells 
with a disrupted TR gene and classified into two groups: Type I cells have amplified 
subtelomeric DNA and depend on Rad51, and Type II cells have elongated telomere 
repeats and require the function of MRX (MRN homolog) (61, 62). As Type II yeast 
cells and ALT cells have elongated telomere repeats, it is thought that these pathways 
depend on a conserved mechanism. It is significant that both human RAD51 and MRN 
are localized at APBs, suggesting that both of them are related to the ALT pathway. It is 
unknown whether the ALT pathway is made up of subpathways, as in Types I and II 
cells of budding yeast. 
As in human ALT cells, budding yeast Type II cells harbor t-circles. When a 
model circular telomere DNA was introduced into Type II cells, this DNA was copied 
to chromosome ends to form a tandem array (63-65). These results can be explained by 
RCR, in which the model circular DNA is utilized as a template for amplification. RCR 
may also play a crucial role in the replication of the linear mitochondrial DNA of the 
yeast Candida parapsilosis. Replication intermediates of the ends of mitochondrial 
DNA include a strand-specific ss DNA structure (33) that is commonly observed in 
RCR. These findings imply that RCR may be a conserved and general mechanism for 
the telomerase-independent pathway in eukaryotes. 
 The mouse knockout mutant of any genes of interest is one of the best model 
systems for human biology. Survivor cells from Terc (TR)
-/-
 apparently maintained their 
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telomere DNA in a telomerase-independent manner. In a cell line established from 
Terc
-/-
 embryonic stem (ES) cells, the tandem arrays of telomeric and non-telomeric 
sequences were observed at the chromosome ends (66). Interestingly, most of the 
chromosome ends contained the same arrays. This suggests that these cells can amplify 
the arrays to maintain the chromosome ends. An array of this unique sequence was 
possibly built at one chromosome end at first, and then it expanded to the other 
chromosome ends. In an example of a human telomerase-negative cell line, the array of 
telomeric and ectopic DNA sequences (derived from SV40 DNA) was attached to most 
of the chromosome ends (50, 51). These cells harbored circular extrachromosomal DNA 
that includes the similar sequence to the array at the chromosome ends, suggesting that 
the circular DNAs may be analogous to t-circles in ALT cells. It is interesting to 
examine whether the circular episome is required for the lengthening of the 
chromosome ends in these cells. Another survivor cell line from Terc
-/-
 mouse 
embryonic fibroblasts showed heterogeneous telomere DNA lengths and the formation 
of APBs (67). This would serve as an invaluable model system for the human ALT 
pathway and cancer development. 
The ES cells from knockout mice mutated in DNA methyltransferase 
(DNMT) genes showed frequent T-SCE and APB formation, even though the cell lines 
were positive for telomerase activity (68). DNA hypomethylation at the subtelomere 
region was observed in those cells. This suggests that the epigenetic state of the cells 
may affect the frequency of T-SCE and APB formation. In human ALT cells, on the 
other hand, the relationship between the methylation status at the subtelomere region 
and T-SCE frequency was less clear (69). 
 
Conclusions 
Several lines of evidence strongly suggest that the ALT pathway is dependent on HR. 
First, a DNA fragment in the telomere repeats of chromosome ends can be copied into 
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the ends of different chromosomes in ALT cells. Second, several kinds of proteins 
essential for HR are localized at APB. Third, a defect in some HR proteins induces 
erosion of telomere DNA in ALT cells. Lastly, the unique structures of telomere DNA 
found in ALT cells, such as ss telomere DNA and circular ECTR, may represent the 
intermediates and/or substrates of the elongation mechanisms based on HR. Importantly, 
the similar telomere DNA structures are also observed in cells that utilize HR-mediated 
telomere maintenance in other organisms. For the further elucidation of the ALT 
pathway, it is essential to establish a model experiment system in order to acquire direct 
evidence of the mechanism of HR-dependent telomere elongation.  
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Table I 






53BP1 LK DDR (37, 43) 
ATM L DDR; PIKK (46) 
ATR LK DDR; PIKK (57) 
BLM LK DSBR; RecQ-like helicase (47, 48, 70) 
BRCA1 L HR; breast cancer 1 (71) 
Cdk2 L Cell cycle; CDK (58) 
COUP-TF1 L Unknown; orphan nuclear receptor (59) 
COUP-TF2 L Unknown; orphan nuclear receptor (59) 
ERCC1 L Excision repair; endonuclease (72) 
FANCA K DSBR (57) 
FANCD2 LK DSBR (57) 
FANCJ L DSBR; structure-specific DNA helicase (59) 
FANCL K DSBR; E3 ubiquitin ligase (57) 
FEN1 K Replication; flap endonuclease (55) 
!-H2AX L DSB marker; phosphorylated H2AX (36, 37) 
hnRNP A2 L Regulator of splicing; hnRNP (73) 
HUS1 L DDR; 9-1-1 PCNA-like clamp (36) 
HP1# LK Heterochromatin (58) 
HP1" LK Heterochromatin (58) 
HP1! LK Heterochromatin (58) 
HSP90 L Heat shock protein (47) 
MDC1 L DDR (37) 
MMS21 LK DDR; E3 SUMO ligase in SMC5/6 (41) 
MRE11 LK HR; MRN complex subunit (42, 43, 74) 
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MUS81 LK HR; structure-specific endonuclease (53) 
NBS1 LK HR; MRN complex subunit (42, 43, 74) 
NXP2 L PML body (59) 
p21 LK Regulator of growth; CDK inhibitor (58) 
p53 LE
¶
 Tumor suppression; transcription factor (46, 58) 
PARP2 L DSBR; poly (ADP-ribose) polymerase (75) 
PCNA LK Replication; clamp  (58) 
PML LK PML body (34, 43) 
POT1 L Shelterin; ss telomere DNA binding (48) 
RAD1 L DDR; 9-1-1 PCNA-like clamp (36) 
RAD9 L DDR; 9-1-1 PCNA-like clamp (36) 
RAD17 L DDR; chromatin loader for 9-1-1 clamp (36) 
RAD50 LK HR; MRN complex subunit (41-43, 74) 
RAD51 LK HR; RecA-like, strand exchange protein (34, 41) 
RAD51D LK HR; resolution of Holliday junction (54) 
RAD52 L HR; DNA binding protein (34) 
RAP1 LK Shelterin; TRF2-interacting (43, 71) 
RIF1 L DDR (76) 
RIP140 L Transcription; co-regulator (59) 
RPA32 LK Replication and HR; ss DNA binding (56) 
RPA70 LK Replication and HR; ss DNA binding (56) 
SMC5 LK DDR; structural maintenance complex (41) 
SMC6 L DDR; structural maintenance complex (41) 
Sp-100 LKE PML body (40, 43, 71) 
STN1 L Telomere; ss DNA binding CST complex (77) 
TEP1 L Telomere (47) 
TF4 L Unknown; orphan nuclear receptor (59) 
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TIN2 LK Shelterin (43, 48) 
TopoII# L DNA structure; topoisomerase, type II (47) 
TopoIII# LK DNA structure; topoisomerase, type IA (48) 
TRF1 LK Shelterin; ds telomere DNA binding (34, 43) 
TRF2 LK Shelterin; ds telomere DNA binding (34, 43, 46) 
WRN LK HR; RecQ-like helicase and nuclease (78, 79) 
XPF L Excision repair; endonuclease (72) 
XRCC3 K HR, resolution of Holliday junction (44) 
 
*
 L: Localization at telomeres in ALT cells. K: Knockdown of gene. E: Ectopic 
expression of protein. 
§
 CDK: Cyclin-dependent kinase. DDR: DNA damage response. DSB: ds DNA break. 
DSBR: ds DNA break repair. HR: Homologous recombination. PIKK: Phosphoinositide 
3-kinase related kinase. PML-B: PML body. 
¶
 Activation of p53 by RNAi of SV40 large T-antigen. 
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Figure legends 
Fig. 1 Telomere structure and lengthening. (A) Vertebrate telomere DNA. (B) 
Shelterin complex in human cells. (C) End-replication problem. The G-strand (red) is 
completely replicated to the end. However, the C-strand (blue) of telomere DNA is 
synthesized as a lagging strand and thus the copy of the very end cannot be 
accomplished. This causes the gradual shortening of telomere DNA through rounds of 
cell divisions. (D) Two types of telomere lengthening mechanism. The G-strand is 
primarily elongated in the telomerase pathway (top). Telomerase-independent pathway 
(bottom) is generally recombination-mediated.  
 
Fig. 2 CO-FISH analysis and T-SCE. (A) Outline of CO-FISH method. The nascent 
DNA strands (pale blue) are labeled with BrdU and BrdC and they can be specifically 
degraded. The template strands are exposed and can be hybridized with the florescent 
G- or C-probe (green or red bar). The signal of each probe can be observed at telomere 
of each one of sister chromatids. (B) Observation of T-SCE by CO-FISH. When T-SCE 
is occurred after DNA replication, the signals of CO-FISH can be observed at the both 
sister telomeres. 
 
Fig. 3 Telomere DNA metabolism in ALT cells. Four types of recombination events 
result in particular DNA metabolisms and unique products. (A) Recombination within 
t-loop causes rapid telomere shortening and t-circle formation. (B) Recombination 
between telomeres of chromosome ends initiates break-induced replication. (C) 
Transfer of a strand of t-circle into telomeres at chromosomal DNA initiates integration 
of the repetitive DNA. (D) Invasion of t-circle by G-tail triggers rolling-circle 
replication. 
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Fig. 4 Formation and resolution of the Holliday junction. The reciprocal exchange 
between two ds DNA (top, red/blue and pink/pale blue) is shown. The Holliday junction 
(middle) is a cruciform DNA formed in HR, and the resolution (bottom) requires cut 
and ligation at the junction. 




